首页 » 文章 » 文章详细信息
BioMed Research International Volume 2017 ,2017-04-04
Prevalence of Diabetes Type 2 in Hepatitis C Infected Patients in Kpk, Pakistan
Research Article
Ghani Ur Rehman 1 Mohammad Ali 1 Farooq Shah 2 Amjad Iqbal 2 , 3 Ayaz Ahmad 4 , 5 Zafar Hayat 2 Badshah Islam 2 Farman Ali 2 Yousaf Jamal 6 Sartaj Alam 7 Muhammad Sajjad 5 Muhammad Zeeshan Bhatti 8
Show affiliations
DOI:10.1155/2017/2416281
Received 2016-10-11, accepted for publication 2016-12-22, Published 2016-12-22
PDF
摘要

Hepatitis C (HCV) and diabetes mellitus are the two main health concerns that cause devastating health and financial worries worldwide. It has been observed in the past that both diseases have a high correlation that might be due to the abnormal conditions of the liver. But the mechanism of the prevalence of diabetes in patients with chronic HCV infection still remains unclear. In our study, we have investigated T2DM in the male and female patients at Lady Reading Hospital (LRH), Peshawar. The blood samples of both in- and outpatients were analysed in the PCR laboratories of LRH from December 2014 to April 2015. Great prevalence of diabetes in hepatitis C infected male and female patients was observed during this study. The data were collected from the patients through a preplanned questionnaire that included name of the patient, HCV, being diabetic, age, gender, location, educational background, family history of the disease, other diseases, and any treatments if taken. The results of our study have found 26.42% prevalence of T2DM in HCV infected patients. So we conclude that HCV infection may be one of the reasons that could lead to T2DM.

授权许可

Copyright © 2017 Ghani Ur Rehman et al. 2017
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

图表

Incidence of HCV infection in male and female patients at LRH, Peshawar.

Magnitude of HCV infection in patients from various age groups.

Prevalence of diabetes in male and female patients at LRH, Peshawar.

通讯作者

Amjad Iqbal.Department of Agriculture, Abdul Wali Khan University Mardan, Mardan, Pakistan, awkum.edu.pk;Coconut Research Institute, Chinese Academy of Tropical Agricultural Sciences, Wenchang City, Hainan 571339, China, catas.cn.amjadiqbal147@yahoo.com

推荐引用方式

Ghani Ur Rehman,Mohammad Ali,Farooq Shah,Amjad Iqbal,Ayaz Ahmad,Zafar Hayat,Badshah Islam,Farman Ali,Yousaf Jamal,Sartaj Alam,Muhammad Sajjad,Muhammad Zeeshan Bhatti. Prevalence of Diabetes Type 2 in Hepatitis C Infected Patients in Kpk, Pakistan. BioMed Research International ,Vol.2017(2017)

您觉得这篇文章对您有帮助吗?
分享和收藏
0

是否收藏?

参考文献
[1] B. Younas, G. M. Khan, M. A. Chaudhary. (2000). Prevalence of diabetes mellitus among patients suffering from chronic liver disease. Mother and Child.38(1):37-40. DOI: 10.1002/hep.22759.
[2] I. A. Shah, S. Shah, Z. Hayat, M. Noor. et al.(2011). Impaired glucose tolerance in HCV/HBV cirrhosis. Journal of Postgraduate Medical Institute.14(1):68-72. DOI: 10.1002/hep.22759.
[3] W. Qidwai, T. Ashfaq. (2010). Imminent epidemic of diabetes mellitus in Pakistan: issues and challenges for health care providers. Journal of Liaquat University of Medical and Health Sciences.9(3):112-113. DOI: 10.1002/hep.22759.
[4] American Diabetes Association. (2014). Diagnosis and classification of diabetes mellitus. Diabetes Care.37:S81-S90. DOI: 10.1002/hep.22759.
[5] A. Antonelli, C. Ferri, S. M. Ferrari, M. Colaci. et al.(2009). Endocrine manifestations of hepatitis C virus infection. Nature Clinical Practice Endocrinology and Metabolism.5(1):26-34. DOI: 10.1002/hep.22759.
[6] M. G. Ghany, D. B. Strader, D. L. Thomas, L. B. Seeff. et al.(2009). Diagnosis, management, and treatment of hepatitis C: an update. Hepatology.49(4):1335-1374. DOI: 10.1002/hep.22759.
[7] C. D. Williams, J. Stengel, M. I. Asike, D. M. Torres. et al.(2011). Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology.140(1):124-131. DOI: 10.1002/hep.22759.
[8] American Diabetes Association. (2012). Diagnosis and classification of diabetes mellitus. Diabetes Care.36, supplement 1:S67-S74. DOI: 10.1002/hep.22759.
[9] A. S. Shera, F. Jawad, A. Maqsood. (2007). Prevalence of diabetes in Pakistan. Diabetes Research and Clinical Practice.76(2):219-222. DOI: 10.1002/hep.22759.
[10] C. Sarrazin, B. C. Gärtner, D. Sizmann, R. Babiel. et al.(2006). Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5. Journal of Clinical Microbiology.44(3):729-737. DOI: 10.1002/hep.22759.
[11] S. Akhtar, S. Rozi. (2009). An autoregressive integrated moving average model for short-term prediction of hepatitis C virus seropositivity among male volunteer blood donors in Karachi, Pakistan. World Journal of Gastroenterology.15(13):1607-1612. DOI: 10.1002/hep.22759.
[12] P. Zhao, J.-B. Wang, J. Jiao. (2006). Investigation on the incidence of diabetes in chronic hepatitis C patients and their HCV genotypes. Zhonghua Gan Zang Bing Za Zhi.14(2):86-88. DOI: 10.1002/hep.22759.
[13] D. L. White, V. Ratziu, H. B. El-Serag. (2008). Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. Journal of Hepatology.49(5):831-844. DOI: 10.1002/hep.22759.
[14] A. Medhat, M. Shehata, L. S. Magder, N. Mikhail. et al.(2002). Hepatitis C in a community in Upper Egypt: risk factors for infection. American Journal of Tropical Medicine and Hygiene.66(5):633-638. DOI: 10.1002/hep.22759.
[15] C. E. Gordon, E. M. Balk, B. N. Becker, P. A. Crooks. et al.(2008). KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD. American Journal of Kidney Diseases.52(5):811-825. DOI: 10.1002/hep.22759.
[16] J. E. Shaw, P. Z. Zimmet, D. McCarty, M. De Courten. et al.(2000). Type 2 diabetes worldwide according to the new classification and criteria. Diabetes Care.23(2):B5-B10. DOI: 10.1002/hep.22759.
[17] D. Lavanchy. (2009). The global burden of hepatitis C. Liver International.29(1):74-81. DOI: 10.1002/hep.22759.
文献评价指标
浏览 123次
下载全文 49次
评分次数 0次
用户评分 0.0分
分享 0次